David Nathanson
University of California, Los Angeles
H-index: 32
North America-United States
Top articles of David Nathanson
PDXpower: A Power Analysis Tool for Experimental Design in Pre-clinical Xenograft Studies for Uncensored and Censored Outcomes
arXiv preprint arXiv:2404.08927
2024/4/13
D-2-HG Inhibits IDH1mut Glioma Growth via FTO Inhibition and Resultant m6A Hypermethylation
Cancer Research Communications
2024/3/22
Compositions and methods for treating cancer
2014/6/12
Combination Therapy with Mtor Inhibition and Ionizing Radiation in Meningioma Results In Superior Cytostatic Effect than Monotherapy
Journal of Neurological Surgery Part B: Skull Base
2024/2
Basal BCL-2-Interacting Mediator of Cell Death (BIM) Responsiveness Correlates with Radiosensitivity in Meningioma
Journal of Neurological Surgery Part B: Skull Base
2024/2
Amine‐weighted chemical exchange saturation transfer magnetic resonance imaging in brain tumors
NMR in Biomedicine
2023/6
Targeting the intrinsic apoptotic machinery in glioblastoma
2023/2/9
Functional Classification of Apoptotic Sensitivity in Meningioma
Journal of Neurological Surgery Part B: Skull Base
2023/2
18 F-Labeled brain-penetrant EGFR tyrosine kinase inhibitors for PET imaging of glioblastoma
Chemical Science
2023
Corrigendum to: EGFR, the Lazarus target for precision oncology in glioblastoma
Neuro-oncology
2023/1
Non-invasive functional companion assays for oncogene targeted therapy for brain cancer
2023/11/9
Targeting deoxycytidine kinase improves symptoms in mouse models of multiple sclerosis
Immunology
2023/1/1
MODL-05. ELUCIDATING THE EPIGENETIC DRIVEN TRANSCRIPTIONAL PROGRAM UNDERLYING THE INVASIVE PHENOTYPE OF THE NOVEL EGFRA289VARIANT OF GBM
Neuro-Oncology
2023/11/1
1491 Aberrant EGFR activation drives enhanced infiltration of immunosuppressive microglia and macrophages in the glioblastoma tumor immune microenvironment
2023/11/1
M2 isoform of pyruvate kinase rewires glucose metabolism during radiation therapy to promote an antioxidant response and glioblastoma radioresistance
Neuro-Oncology
2023/11/1
Depth of Radiographic Response and Time to Tumor Regrowth Predicts Overall Survival Following Anti-VEGF Therapy in Recurrent Glioblastoma
Clinical Cancer Research
2023/10/13
Calculation of ATP production rates using the Seahorse XF Analyzer
EMBO reports
2023/10/9
Differential Susceptibility of Ex Vivo Primary Glioblastoma Tumors to Oncolytic Effect of Modified Zika Virus
Cells
2023/9/29
Immune checkpoint blockade induces distinct alterations in the microenvironments of primary and metastatic brain tumors
Journal of Clinical Investigation
2023/9/1
Glioblastoma Mesenchymal Transition and Invasion are Dependent on a NF-κB/BRD2 Chromatin Complex
2023/7/3